Login to Your Account



BIA: Rare disease drugs in U.K. could lose in NHS/NICE proposal

By Nuala Moran
Staff Writer

Friday, January 13, 2017

LONDON – A proposal intended to speed market access for companies and get innovative products to patients more quickly has been blasted by the U.K. Bioindustry Association (BIA), which said it could block treatments for very rare diseases.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription